Table 2.

Univariate analysis of prognostic factors associated with relapse

Prognostic factor	HR (95% CI)	P
National Cancer Institute High risk	1.90 (0.97–3.71)	0.062
Bulky disease	1.06 (0.55–2.06)	0.859
Poor Prephase response (blast count cut-off: 1000/µL)	1.19 (0.42–3.39)	0.745
Poor Prephase response (blast count cut-off: 0/µL)	2.45 (1.23–4.89)	0.011
Favourable genetics	0.6 (0.29–1.25)	0.175
High risk genetics	2.85 (0.86–9.38)	0.085
Day 15 M3 bone marrow	0.64 (0.09–4.74)	0.664
Positive Day 35 minimal residual disease	2.92 (1.50–5.69)	0.002